A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms

[1]  Jean-François Fisette,et al.  Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA Splicing , 2006, PLoS biology.

[2]  F. Claverie-Martin,et al.  The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping , 2005, Journal of Human Genetics.

[3]  M. Thakur,et al.  Estradiol regulates APP mRNA alternative splicing in the mice brain cortex , 2005, Neuroscience Letters.

[4]  M. Gabut,et al.  The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1α Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis , 2005, Molecular and Cellular Biology.

[5]  H. Xia.  Regulation of γ-Fibrinogen Chain Expression by Heterogeneous Nuclear Ribonucleoprotein A1* , 2005, Journal of Biological Chemistry.

[6]  A. Prats,et al.  Heterogeneous Nuclear Ribonucleoprotein A1 Is a Novel Internal Ribosome Entry Site trans-Acting Factor That Modulates Alternative Initiation of Translation of the Fibroblast Growth Factor 2 mRNA* , 2005, Journal of Biological Chemistry.

[7]  M. Garcia-Blanco,et al.  Alternative splicing in disease and therapy , 2004, Nature Biotechnology.

[8]  B. Rowan,et al.  Selective estrogen receptor modulator regulated proteins in endometrial cancer cells , 2004, Molecular and Cellular Endocrinology.

[9]  Samir K. Brahmachari,et al.  Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition , 2004, Bioinform..

[10]  B. O’Malley,et al.  Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[12]  F. Liu,et al.  Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5 , 2003, FEBS letters.

[13]  A. Ganguly,et al.  Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A , 2003, Human Genetics.

[14]  Gerd Bicker,et al.  Turning teratocarcinoma cells into neurons: rapid differentiation of NT-2 cells in floating spheres. , 2003, Brain research. Developmental brain research.

[15]  J. Adams,et al.  Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Beck,et al.  Recruitment of Heterogeneous Nuclear Ribonucleoprotein A1in Vivo to the LMP/TAP Region of the Major Histocompatibility Complex* , 2003, The Journal of Biological Chemistry.

[17]  B. Graveley.  Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.

[18]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[19]  A. Hartmann,et al.  A trans-acting factor, isolated by the three-hybrid system, that influences alternative splicing of the amyloid precursor protein minigene. , 2000, European journal of biochemistry.

[20]  Michael Q. Zhang,et al.  Exonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions , 2000, Molecular and Cellular Biology.

[21]  C. Masters,et al.  The amyloid beta-protein precursor of Alzheimer's disease is degraded extracellularly by a Kunitz protease inhibitor domain-sensitive trypsin-like serine protease in cultures of chick sympathetic neurons. , 1999, European journal of biochemistry.

[22]  I. Lieberburg,et al.  Cellular mechanisms of beta-amyloid production and secretion. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Blanchette,et al.  Modulation of exon skipping by high‐affinity hnRNP A1‐binding sites and by intron elements that repress splice site utilization , 1999, The EMBO journal.

[24]  L. Chasin,et al.  Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1. , 1999, Nucleic acids research.

[25]  C. Masters,et al.  Relative Increase in Alzheimer’s Disease of Soluble Forms of Cerebral Aβ Amyloid Protein Precursor Containing the Kunitz Protease Inhibitory Domain* , 1998, The Journal of Biological Chemistry.

[26]  S. Younkin,et al.  The Alternatively Spliced Kunitz Protease Inhibitor Domain Alters Amyloid β Protein Precursor Processing and Amyloid β Protein Production in Cultured Cells* , 1996, The Journal of Biological Chemistry.

[27]  M. Hattori,et al.  Identification of cis-acting elements involved in an alternative splicing of the amyloid precursor protein (APP) gene. , 1996, Gene.

[28]  S. Spitalnik,et al.  The role of glycosylation in synthesis and secretion of beta-amyloid precursor protein by Chinese hamster ovary cells. , 1996, Archives of biochemistry and biophysics.

[29]  A. Schmaier,et al.  Protease Nexin-2/Amyloid β-Protein Precursor Inhibits Factor Xa in the Prothrombinase Complex (*) , 1995, The Journal of Biological Chemistry.

[30]  T. Tsukahara,et al.  Regulation of alternative splicing in the amyloid precursor protein (APP) mRNA during neuronal and glial differentiation of P19 embryonal carcinoma cells , 1995, Brain Research.

[31]  C. Burd,et al.  RNA binding specificity of hnRNP A1: significance of hnRNP A1 high‐affinity binding sites in pre‐mRNA splicing. , 1994, The EMBO journal.

[32]  Raymond,et al.  Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. , 1993, The Journal of clinical investigation.

[33]  H. E. Kennedy,et al.  Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity. , 1993, Biochemical and biophysical research communications.

[34]  A. Schmaier,et al.  Potential Role of Protease Nexin‐2/Amyloid β‐Protein Precursor as a Cerebral Anticoagulant a , 1992 .

[35]  R. Martins,et al.  Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization , 1992 .

[36]  Thomas W. Glover,et al.  A de novo Alu insertion results in neurofibromatosis type 1 , 1991, Nature.

[37]  M. Batzer,et al.  Evolution of the master Alu gene(s) , 1991, Journal of Molecular Evolution.

[38]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[39]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[40]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[41]  C. Masters,et al.  AMYLOID PLAQUE CORE PROTEIN IN ALZHEIMERʼS DISEASE AND AGED DOWNʼS SYNDROME , 1985 .

[42]  H. Xia.  Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. , 2005, The Journal of biological chemistry.

[43]  Brenton R Graveley,et al.  The origins and implications of Aluternative splicing. , 2004, Trends in genetics : TIG.

[44]  E. Androphy,et al.  The regulation and regulatory activities of alternative splicing of the SMN gene. , 2004, Critical reviews in eukaryotic gene expression.

[45]  W. Bowen,et al.  HnRNP-A1 binds directly to double-stranded DNA in vitro within a 36 bp sequence , 2004, Molecular and Cellular Biochemistry.

[46]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[47]  S. Younkin,et al.  The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. , 1996, The Journal of biological chemistry.

[48]  R. Martins,et al.  Human brain beta A4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization. , 1992, Journal of neurochemistry.

[49]  K. Grzeschik,et al.  The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor , 1987 .

[50]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.